Results 171 to 180 of about 286,717 (340)
Abstract CD300e is a marker of mature monocytes in flow cytometry; however, there is limited detailed information on staining patterns in conjunction with other monocyte markers. We evaluated the flow cytometric staining patterns of CD64, CD14, and CD300e in 12 negative and 33 positive peripheral blood specimens and 16 negative and 56 positive bone ...
Jenny Zhang +2 more
wiley +1 more source
THAP11 expression profile during differentiation of cord blood CD34<sup>+</sup> cells.
Xiangzhen Kong +14 more
openalex +2 more sources
Differentielle DNA Methylierung und Analysen zum Transkriptionsfaktor hoxA9 in CD34+ hämatopoetischen Vorläuferzellen [PDF]
Isabelle Hellwig
openalex +1 more source
TimeFlow 2: An Unsupervised Cell Lineage Detection Method for Flow Cytometry Data
TimeFlow 2 is a new method for cell lineage inference in flow cytometry data. It constructs cell state paths along pseudotime and aggregates them into biologically informative groups. It allows tracking of cytometry markers within each automatically inferred lineage.
Margarita Liarou +2 more
wiley +1 more source
ABSTRACT Fine‐needle aspiration cytology specimens are frequently utilized for ancillary studies to identify diagnostic and prognostic information. This case highlights diagnostic pitfalls and challenges in diagnosing NUTM1‐rearranged neoplasia on pancreatic cytology.
Terrance J. Lynn
wiley +1 more source
IL‐1β inhibits ILC3 while favoring NK‐cell maturation of umbilical cord blood CD34+ precursors [PDF]
Paolo Ambrosini +5 more
openalex +1 more source
ABSTRACT Malignant mesothelioma (MM) is a rare yet aggressive neoplasm that arises from mesothelial cells lining the thoracic and abdominal cavities, the pericardium, and the tunica testis. Characterized by rapid progression, high invasiveness, and a poor prognosis, MM poses significant clinical challenges. SMARCB1, also referred to as INI‐1, hSNF5, or
Jun Yang +4 more
wiley +1 more source
Cell State Transitions Drive the Evolution of Disease Progression in B-Lymphoblastic Leukemia. [PDF]
Gravenmier C +7 more
europepmc +1 more source

